HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by LeBlang, S. D. Articles by Steinberg, F. L. Search for Related Content PubMed PubMed Citation Articles by LeBlang, S. D. Articles by Steinberg, F. L. Social Bookmarking                      What's this? Hotlight (NEW!) What's Hotlight?

Leiomyoma Shrinkage After MRI-Guided Focused Ultrasound Treatment: Report of 80 Patients

¹ All authors: Department of Radiology, University Imaging-Guided Therapy Center, 3848 FAU Blvd., Ste. 200, Boca Raton, FL 33431.

OBJECTIVE. The purpose of this study was to assess the degree of leiomyoma ablation and shrinkage after MRI-guided focused ultrasound treatment performed according to U.S. Food and Drug Administration protocols for commercial trials.

MATERIALS AND METHODS. A total of 147 symptomatic leiomyomas in 80 women (average age, 46 years; range, 34–55 years) were managed with MRI-guided focused ultrasound. The average volume of treated fibroids was 175 ± 201 (SD) cm³. Before treatment, T2-weighted MR images in three planes were obtained to measure leiomyoma volume. Immediately after treatment, T1-weighted contrast-enhanced fat-suppressed MR images in three planes were used to measure nonperfused volume ratio. Similar images obtained 6 months after treatment were used to determine leiomyoma shrinkage. Qualitative and quantitative relations between fibroid volume, nonperfused volume ratio at treatment, and 6-month shrinkage were measured.

RESULTS. The average nonperfused volume ratio was 55% ± 25% immediately after treatment. Six months after treatment, the average volume of treated fibroids had decreased to 112 ± 141 cm³ (n = 81) (p < 0.0001) with an average volume reduction of 31% ± 28%. A linear regression model showed highly significant correlation between posttreatment nonperfused volume ratio and shrinkage at 6 months (p < 0.0001).

CONCLUSION. MRI-guided focused ultrasound therapy for leiomyoma can result in nonperfused volume ratio and shrinkage that exceed those in previous clinical trials because the treatment guidelines have been relaxed to allow a greater amount of tissue ablation. The results suggest that a larger nonperfused volume ratio can be achieved, resulting in greater shrinkage and improved relief of symptoms.

Keywords: ablation • fibroid • leiomyoma • MRI-guided focused ultrasound

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?